Search results

Journal Article (27)

  1. Journal Article
    Krahn, A.; Lottmann, P.; Marquardsen, T.; Tavernier, A.; Tuerke, M. T.; Reese, M.; Leonov, A.; Bennati, M.; Hoefer, P.; Engelke, F. et al.; Griesinger, C.: Shuttle DNP spectrometer with a two-center magnet. Physical Chemistry Chemical Physics 12 (22), pp. 5830 - 5840 (2010)
  2. Journal Article
    Montaville, P.; Condevylle, N.; Radhakrishnan, A.; Leonov, A.; Zweckstetter, M.; Becker, S.: The PIP2 binding mode of the C2 domains of rabphilin-3A. Protein Science 17 (6), pp. 1025 - 1034 (2008)
  3. Journal Article
    Schuetz, A.; Junker, J.; Leonov, A.; Lange, O.; Molinski, T. F.; Griesinger, C.: Stereochemistry of sagittamide a from residual dipolar coupling enhanced NMR. Journal of the American Chemical Society 129 (49), pp. 15114 - 15115 (2007)
  4. Journal Article
    Montaville, P.; Schlicker, C.; Leonov, A.; Zweckstetter, M.; Sheldrick, G. M.; Becker, S.: The C2A-C2B linker defines the high affinity Ca2+ binding mode of rabphilin-3A. Journal of Biological Chemistry 282 (7), pp. 5015 - 5025 (2007)
  5. Journal Article
    Rodriguez-Castaneda, F.; Haberz, P.; Leonov, A.; Griesinger, C.: Paramagnetic tagging of diamagnetic proteins for solution NMR. Magnetic Resonance in Chemistry 44 (Sp. Iss. S1), pp. S10 - S16 (2006)
  6. Journal Article
    Haberz, P.; Rodriguez-Castaneda, F.; Junker, J.; Becker, S.; Leonov, A.; Griesinger, C.: Two new chiral EDTA-based metal chelates for weak alignment of proteins in solution. Organic Letters 8 (7), pp. 1275 - 1278 (2006)
  7. Journal Article
    Leonov, A.; Voigt, B.; Rodriguez-Castaneda, F.; Sakhaii, P.; Griesinger, C.: Convenient synthesis of multifunctional EDTA-based chiral metal chelates substituted with an S-mesylcysteine. Chemistry-A European Journal 11 (11), pp. 3342 - 3348 (2005)

Conference Paper (7)

  1. Conference Paper
    Buss, S.; Kuebler, L.; Maurer, A.; Schmidt, F.; Leonov, A.; Ryazanov, S.; Giese, A.; Griesinger, C.; Pichler, B. J.; Herfert, K.: In vitro evaluation of small molecule compounds as potential PET tracers targeting a-synuclein. 29th International Symposium on Cerebral Blood Flow, Metabolism and Function / 14th International Conference on Quantification of Brain Function with PET (BRAIN and BRAIN Pet), Yokohama, Japan, July 04, 2019 - July 07, 2019. Journal of Cerebral Blood Flow and Metabolism (2019)
  2. Conference Paper
    Antonschmidt, L.; Dervisoglu, R.; Ryazanov, S.; Leonov, A.; Wegstroth, M.; Giller, K.; Becker, S.; Benz, R.; Eichele, G.; Fischer, A. et al.; Giese, A.; Andreas, L.; Griesinger, C.: Protein-drug interactions in the membrane: The small molecule Anle138b and its binding to alpha-synuclein oligomers. 63rd Annual Meeting of the Biophysical-Society, Baltimore, MD, March 02, 2019 - March 06, 2019. Biophysical Journal (2019)
  3. Conference Paper
    Antonschmidt, L.; Dervisoglu, R.; Ryazanov, S.; Leonov, A.; Wegstroth, M.; Giller, K.; Becker, S.; Lee , J.; Lal , R.; Eichele, G. et al.; Fischer , A.; Giese, A.; Andreas, L.; Griesinger, C.: The small molecule anle138b shows interaction with alpha-synuclein oligomers in phospholipid membranes. 62nd Annual Meeting of the Biophysical-Society, San Francisco, CA, February 17, 2018 - February 21, 2018. Biophysical Journal (Suppl), p. 560a - 560a (2018)
  4. Conference Paper
    Sadasivam, S. M.; Ryazanov, S.; Leonov, A.; Roeters, S.; Wouterson, S.; Giese, A.; Griesinger, C.; Killian, J. A.: Effect of the novel amyloid inhibitor "anle145c" on aggregation of islet amyloid polypeptide and how it is modulated by membranes. 60th Annual Meeting of the Biophysical-Society, Los Angeles, CA, February 27, 2016 - March 02, 2016. Biophysical Journal 110 (Suppl 1), p. 420A - 420A (2016)
  5. Conference Paper
    Prix, C.; Schmidt, F.; Levin, J.; Schinke, K.; Shi, S.; Ryazanov, S.; Leonov, A.; Högen, T.; Mitteregger-Kretzschmar, G.; Kretzschmar, H. A. et al.; Bötzel, K.; Griesinger, C.; Giese, A.: The oligomer modulator anle138b is effective in the prodromal phase of a transgenic mouse model of Parkinson's disease. Joint Congress of European Neurology, Istanbul, Turkey, May 31, 2014 - June 03, 2014. European Journal of Neurology 21 (Suppl. 1), p. 170 - 170 (2014)
  6. Conference Paper
    Kretzschmar, H.; Wagner, J.; Ryazanov, S.; Leonov, A.; Levin, J.; Shi, S.; Prix, C.; Groschup, M.; Griesinger, C.; Giese, A.: Causal therapy of prion and Parkinson's disease with novel inhibitors of protein aggregation. 87th Annual Meeting of the American Association of Neuropathologists, Seattle, WA, June 23, 2011 - June 26, 2011. Journal of Neuropathology and Experimental Neurology 70 (6), p. 505 - 505 (2011)
  7. Conference Paper
    Levin, J.; Wagner, J.; Ryazanov, S.; Leonov, A.; Shi, S.; Schmidt, F.; Prix, C.; Bertsch, U.; Mitteregger-Kretzschmar, G.; Geissen, M. et al.; Hischberger, T.; Tavan, P.; Pilger, J.; Zweckstetter, M.; Frank, T.; Baehr, M.; Weishaupt, J.; Uhr, M.; Urlaub, H.; Teichmann, U.; Boetzel, K.; Groschup, M.; Kretzschmar, H. A.; Griesinger, C.; Giese, A.: Causal therapy of Parkinson's disease with anle138b, a novel protein aggregation inhibitor. 15th International Congress of Parkinsons Disease and Movement Disorders, Toronto, CANADA, 2011. Movement Disorders 26 (Supplement 2), p. S21 - S21 (2011)

Patent (1)

  1. Patent
    Giese, A.; Bertsch, U.; Kretzschmar, H.; Habeck, M.; Hirschberger, T.; Tavan, P.; Griesinger, C.; Leonov, A.; Ryazanov, S.; Weber, P.: New drug for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseases. WO/2010/00372 (2010)
Go to Editor View